VEGFA and cancer: Over the last decades the development of angiogenesis inhibitors such as Bevacizumab (an anti-VEGF humanized antibody) or tyrosine kinase inhibitors that target the VEGF pathway4 have improved cancer therapies for patients and today antiangiogenic drugs are widely used for the treatment of many solid tumors4, 5.